Safety and Immunogenicity of rSh28GST Antigen in Humans: Phase 1 Randomized Clinical Study of a Vaccine Candidate against Urinary Schistosomiasis

BACKGROUND: Treatment of urinary schistosomiasis by chemotherapy remains challenging due to rapid re-infection and possibly to limited susceptibility to praziquantel treatment. Therefore, therapeutic vaccines represent an attractive alternative control strategy. The objectives of this study were to...

Descripción completa

Detalles Bibliográficos
Autores principales: Riveau, Gilles, Deplanque, Dominique, Remoué, Franck, Schacht, Anne-Marie, Vodougnon, Hubert, Capron, Monique, Thiry, Michel, Martial, Joseph, Libersa, Christian, Capron, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389022/
https://www.ncbi.nlm.nih.gov/pubmed/22802974
http://dx.doi.org/10.1371/journal.pntd.0001704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389022/
https://www.ncbi.nlm.nih.gov/pubmed/22802974
http://dx.doi.org/10.1371/journal.pntd.0001704

Ejemplares similares